Literature DB >> 12363104

Fanconi syndrome caused by sodium valproate: report of three severely disabled children.

Hideto Yoshikawa1, Toru Watanabe, Tokinari Abe.   

Abstract

We report three severely disabled children with epilepsy, a 4-year-old boy, 8-year-old girl and 14-year-old girl, who were treated with sodium valproate from the age of 2 months, 3 months and 7 years, respectively, and who developed Fanconi syndrome. All three patients were bed-ridden and fed by means of a nasogastric or gastrostomy tube. Since Fanconi syndrome was considered to be caused by sodium valproate, it was stopped. After the discontinuation of sodium valproate, renal involvement improved in all patients in 2-12 months. Severely handicapped children may be at risk for sodium valproate-induced renal involvement. Although among the adverse effects of sodium valproate, renal involvement is uncommon, Fanconi syndrome due to valproate therapy has rarely been reported. We have to pay attention to Fanconi syndrome in epileptic children treated with sodium valproate, especially in severely disabled children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12363104     DOI: 10.1053/ejpn.2002.0585

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  11 in total

1.  Anticonvulsant-induced rickets and nephrocalcinosis.

Authors:  Keith K Lau; Koyelle Papneja
Journal:  BMJ Case Rep       Date:  2012-02-25

Review 2.  Valproate-induced Fanconi syndrome in a 27-year-old woman.

Authors:  Sandeep M Patel; Jonathan Graff-Radford; Mark L Wieland
Journal:  J Gen Intern Med       Date:  2011-04-23       Impact factor: 5.128

3.  Fanconi's Syndrome Associated with Prolonged Adefovir Dipivoxil Therapy in a Hepatitis B Virus Patient.

Authors:  Young Kul Jung; Jong Eun Yeon; Jong Hwan Choi; Chung Ho Kim; Eun Suk Jung; Ji Hoon Kim; Jong Jae Park; Jae Seon Kim; Young-Tae Bak; Kwan Soo Byun
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

4.  Autoimmune haemolytic anaemia and renal Fanconi syndrome caused by valproate therapy.

Authors:  Toru Watanabe; Kosuke Nakayasu; Yoshihisa Nagayama
Journal:  Eur J Pediatr       Date:  2004-12-10       Impact factor: 3.183

5.  Risk factors for sodium valproate-induced renal tubular dysfunction.

Authors:  Satoko Koga; Takahisa Kimata; Sohsaku Yamanouchi; Shoji Tsuji; Ken Yoshimura; Atsushi Araki; Kazunari Kaneko
Journal:  Clin Exp Nephrol       Date:  2017-08-23       Impact factor: 2.801

6.  Secondary renal Fanconi syndrome caused by valproate therapy.

Authors:  Toru Watanabe; Hideto Yoshikawa; Sawako Yamazaki; Yuki Abe; Tokinari Abe
Journal:  Pediatr Nephrol       Date:  2005-03-23       Impact factor: 3.714

Review 7.  Drug-induced acid-base disorders.

Authors:  Daniel Kitterer; Matthias Schwab; M Dominik Alscher; Niko Braun; Joerg Latus
Journal:  Pediatr Nephrol       Date:  2014-11-05       Impact factor: 3.714

Review 8.  The effects of sodium valproate on the renal function of children with epilepsy.

Authors:  Mark Jonathan Knights; Eric Finlay
Journal:  Pediatr Nephrol       Date:  2013-05-30       Impact factor: 3.714

9.  Sodium valproate-induced Fanconi type proximal renal tubular acidosis.

Authors:  Mark Knights; Tina Thekkekkara; Alistair Morris; Eric Finlay
Journal:  BMJ Case Rep       Date:  2016-01-28

10.  Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report.

Authors:  Motoyuki Tanaka; Takao Setoguchi; Yasuhiro Ishidou; Yoshiya Arishima; Masataka Hirotsu; Yoshinobu Saitoh; Shunsuke Nakamura; Hironori Kakoi; Satoshi Nagano; Masahiro Yokouchi; Junichi Kamizono; Setsuro Komiya
Journal:  Diagn Pathol       Date:  2012-08-20       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.